255 related articles for article (PubMed ID: 23159074)
41. Surgical salvage following stereotactic body radiotherapy for early-stage NSCLC.
Allibhai Z; Cho BC; Taremi M; Atallah S; Hope A; Hwang D; Keshavjee S; Tsao M; Yasufuku K; Kim SW; Bezjak A
Eur Respir J; 2012 Apr; 39(4):1039-42. PubMed ID: 22467727
[No Abstract] [Full Text] [Related]
42. Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy.
Hoppe BS; Huh S; Flampouri S; Nichols RC; Oliver KR; Morris CG; Mendenhall NP; Li Z
Radiother Oncol; 2010 Dec; 97(3):425-30. PubMed ID: 20934768
[TBL] [Abstract][Full Text] [Related]
43. Stereotactic radiosurgery for thoracic malignancies.
Cesaretti JA; Pennathur A; Rosenstein BS; Swanson SJ; Fernando HC
Ann Thorac Surg; 2008 Feb; 85(2):S785-91. PubMed ID: 18222218
[TBL] [Abstract][Full Text] [Related]
44. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer.
Grills IS; Mangona VS; Welsh R; Chmielewski G; McInerney E; Martin S; Wloch J; Ye H; Kestin LL
J Clin Oncol; 2010 Feb; 28(6):928-35. PubMed ID: 20065181
[TBL] [Abstract][Full Text] [Related]
45. [The boundaries of curation].
Debus J; Eberhardt W; Hoffmann H; Passlick B; Rübe C; Thomas M
Onkologie; 2010; 33 Suppl 5():12-20. PubMed ID: 20523102
[TBL] [Abstract][Full Text] [Related]
46. Current status and future direction of surgical treatment for non-small cell lung cancer.
Yoshino I
Ann Thorac Cardiovasc Surg; 2009 Feb; 15(1):1-3. PubMed ID: 19262442
[No Abstract] [Full Text] [Related]
47. [Early-stage NSCLC. The renaissance of radiotherapy in early-stage non-small cell lung cancer].
Girard N; Mornex F
Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S79-87. PubMed ID: 18971830
[TBL] [Abstract][Full Text] [Related]
48. Dummy run for a phase II study of stereotactic body radiotherapy of T1-T2 N0M0 medical inoperable non-small cell lung cancer.
Djärv E; Nyman J; Baumann P; Ekberg L; Høyer M; Lax I; Lewensohn R; Levin N; Lund JA; Morhed E; Ericsson SR; Traberg A; Wittgren L; Johansson KA
Acta Oncol; 2006; 45(7):973-7. PubMed ID: 16982566
[TBL] [Abstract][Full Text] [Related]
49. Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: patterns of failure.
Andratschke N; Zimmermann F; Boehm E; Schill S; Schoenknecht C; Thamm R; Molls M; Nieder C; Geinitz H
Radiother Oncol; 2011 Nov; 101(2):245-9. PubMed ID: 21724287
[TBL] [Abstract][Full Text] [Related]
50. Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer.
Sher DJ; Wee JO; Punglia RS
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e767-74. PubMed ID: 21300476
[TBL] [Abstract][Full Text] [Related]
51. Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer: a Markov model-based decision analysis.
Louie AV; Rodrigues G; Hannouf M; Zaric GS; Palma DA; Cao JQ; Yaremko BP; Malthaner R; Mocanu JD
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):964-73. PubMed ID: 20932688
[TBL] [Abstract][Full Text] [Related]
52. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant.
Bradley JD; El Naqa I; Drzymala RE; Trovo M; Jones G; Denning MD
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1146-50. PubMed ID: 19800181
[TBL] [Abstract][Full Text] [Related]
53. Stereotactic radiotherapy for stage I non-small-cell lung cancer--the triumph of technology over biology?
Ball D; Withers HR
Nat Clin Pract Oncol; 2007 Nov; 4(11):614-5. PubMed ID: 17848932
[No Abstract] [Full Text] [Related]
54. Fiducial marker placement using endobronchial ultrasound and navigational bronchoscopy for stereotactic radiosurgery: an alternative strategy.
Harley DP; Krimsky WS; Sarkar S; Highfield D; Aygun C; Gurses B
Ann Thorac Surg; 2010 Feb; 89(2):368-73; discussion 373-4. PubMed ID: 20103300
[TBL] [Abstract][Full Text] [Related]
55. Stereotactic body radiation therapy (SBRT) for lung and liver tumours.
Anand AK; Punnakal AU; Chaudhoory AR; Garg C; Munjal RK; Bansal AK; Sharma R; Kumar R; Kumar G
J Indian Med Assoc; 2012 Jul; 110(7):462-4. PubMed ID: 23520671
[No Abstract] [Full Text] [Related]
56. Surgical staging for non-small cell lung cancer.
Gamliel Z
Surg Oncol Clin N Am; 2011 Oct; 20(4):691-700. PubMed ID: 21986266
[TBL] [Abstract][Full Text] [Related]
57. Stereotactic body radiation therapy for inoperable lung cancer.
Rusthoven KE; Pugh TJ
JAMA; 2010 Jun; 303(23):2354-5; author reply 2355. PubMed ID: 20551403
[No Abstract] [Full Text] [Related]
58. Stereotactic body radiotherapy in lung cancer: an update.
Abreu CE; Ferreira PP; de Moraes FY; Neves WF; Gadia R; Carvalho Hde A
J Bras Pneumol; 2015; 41(4):376-87. PubMed ID: 26398758
[TBL] [Abstract][Full Text] [Related]
59. Salvage surgery after stereotactic radiotherapy: a new challenge for thoracic surgeons.
Van Schil PE
J Thorac Oncol; 2010 Dec; 5(12):1881-2. PubMed ID: 21102256
[No Abstract] [Full Text] [Related]
60. Improving outcomes for high-risk patients with early-stage non-small-cell lung cancer: insights from population-based data and the role of stereotactic ablative radiotherapy.
Palma DA; Senan S
Clin Lung Cancer; 2013 Jan; 14(1):1-5. PubMed ID: 22846581
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
